| 1 |
Hypoglycemia during treatment of acute lymphoblastic leukemia |
|
| | Mary Jiang, Alexandra Ahmet | | | Paediatrics & Child Health. 2023; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Increased referrals for congenital hyperinsulinism genetic testing in children with trisomy 21 reflects the high burden of non-genetic risk factors in this group |
|
| | Thomas I. Hewat, Thomas W. Laver, Jayne A. L. Houghton, Jonna M. E. Männistö, Sabah Alvi, Stephen P. Brearey, Declan Cody, Antonia Dastamani, Miguel De los Santos La Torre, Nuala Murphy, Birgit Rami-Merhar, Birgit Wefers, Hanna Huopio, Indraneel Banerjee, Matthew B. Johnson, Sarah E. Flanagan | | | Pediatric Diabetes. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Blood glucose level during induction phase chemotherapy in childhood acute lymphoblastic leukemia |
|
| | Nunki Andria, Annang Giri Moelyo, Muhammad Reza | | | Paediatrica Indonesiana. 2020; 60(4): 197 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Induction chemotherapy reduces extracellular heat shock protein 72 levels, inflammation, lipoperoxidation and changes insulin sensitivity in children and adolescents newly diagnosed with acute lymphoblastic leukemia |
|
| | Ana Paula Trussardi Fayh, Camila de Carvalho Gomes, Helena Trevisan Schroeder, Carlos Henrique de Lemos Muller, Telma Maria de Araújo Moura Lemos, Mauricio Krause | | | Oncotarget. 2018; 9(47): 28784 | | | [Pubmed] [Google Scholar] [DOI] | |
|
